mRNA nanoparticles drive potent SARS-CoV-2 immunity in mice

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA and computational protein design, producing in mice a potent immune defense against both Wuhan-Hu-1 and omicron BA.5 SARS-CoV-2.